These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 8622316

  • 1. Stage II esophageal carcinoma: the significance of T and N.
    Killinger WA, Rice TW, Adelstein DJ, Medendorp SV, Zuccaro G, Kirby TJ, Goldblum JR.
    J Thorac Cardiovasc Surg; 1996 May; 111(5):935-40. PubMed ID: 8622316
    [Abstract] [Full Text] [Related]

  • 2. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status.
    Rice TW, Zuccaro G, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR.
    Ann Thorac Surg; 1998 Mar; 65(3):787-92. PubMed ID: 9527214
    [Abstract] [Full Text] [Related]

  • 3. Results of en bloc resection for bronchogenic carcinoma with chest wall invasion.
    Burkhart HM, Allen MS, Nichols FC, Deschamps C, Miller DL, Trastek VF, Pairolero PC.
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):670-5. PubMed ID: 11986594
    [Abstract] [Full Text] [Related]

  • 4. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993.
    Inoue K, Sato M, Fujimura S, Sakurada A, Takahashi S, Usuda K, Kondo T, Tanita T, Handa M, Saito Y, Sagawa M.
    J Thorac Cardiovasc Surg; 1998 Sep; 116(3):407-11. PubMed ID: 9731782
    [Abstract] [Full Text] [Related]

  • 5. Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.
    Bryant AS, Pereira SJ, Miller DL, Cerfolio RJ.
    Ann Thorac Surg; 2006 Nov; 82(5):1808-13; discussion 1813-4. PubMed ID: 17062253
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database.
    Crabtree TD, Kosinski AS, Puri V, Burfeind W, Bharat A, Patterson GA, Hofstetter W, Meyers BF.
    Ann Thorac Surg; 2013 Aug; 96(2):382-90. PubMed ID: 23731608
    [Abstract] [Full Text] [Related]

  • 7. A better prognostic value from a modification of lung cancer staging.
    Roeslin N, Chalkiadakis G, Dumont P, Witz JP.
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):504-9. PubMed ID: 2821327
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.
    Zhang HL, Chen LQ, Liu RL, Shi YT, He M, Meng XL, Bai SX, Ping YM.
    Dis Esophagus; 2010 Jan; 23(1):53-8. PubMed ID: 19392846
    [Abstract] [Full Text] [Related]

  • 10. Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study.
    Lafitte JJ, Ribet ME, Prévost BM, Gosselin BH, Copin MC, Brichet AH.
    Ann Thorac Surg; 1996 Sep; 62(3):830-4. PubMed ID: 8784014
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus.
    Tachibana M, Kinugasa S, Dhar DK, Tabara H, Masunaga R, Kotoh T, Kubota H, Nagasue N.
    Arch Surg; 1999 Jan; 134(1):50-4. PubMed ID: 9927130
    [Abstract] [Full Text] [Related]

  • 12. Therapy and prognosis of testicular carcinomas in relation to TNM classification.
    Batata MA, Chu FC, Hilaris BS, Papantoniou PA, Whitmore WF, Golbey RB.
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1287-93. PubMed ID: 7141907
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of non-small cell lung cancer 3 cm or less in diameter.
    Tateishi M, Fukuyama Y, Hamatake M, Kohdono S, Mitsudomi T, Ishida T, Sugimachi K.
    J Surg Oncol; 1995 Aug; 59(4):251-4. PubMed ID: 7630173
    [Abstract] [Full Text] [Related]

  • 14. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival.
    Battafarano RJ, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA.
    Ann Thorac Surg; 2002 Oct; 74(4):988-93; discussion 993-4. PubMed ID: 12400733
    [Abstract] [Full Text] [Related]

  • 15. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
    Newman SB, DeMeester TR, Golomb HM, Hoffman PC, Little AG, Raghavan V.
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
    [Abstract] [Full Text] [Related]

  • 16. Reflux esophagitis and carcinoma.
    Ribet ME, Mensier EA.
    Surg Gynecol Obstet; 1992 Aug; 175(2):121-5. PubMed ID: 1636135
    [Abstract] [Full Text] [Related]

  • 17. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma.
    Mallery S, DeCamp M, Bueno R, Mentzer SJ, Sugarbaker DJ, Swanson SJ, Van Dam J.
    Cancer; 1999 Sep 01; 86(5):764-9. PubMed ID: 10463973
    [Abstract] [Full Text] [Related]

  • 18. [Staging and neoadjuvant therapy of squamous cell carcinoma of esophagus].
    Benhidjeb T, Moesta KT, Schlag PM.
    Ther Umsch; 2001 Mar 01; 58(3):165-73. PubMed ID: 11305155
    [Abstract] [Full Text] [Related]

  • 19. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
    Aronow ME, Portell CA, Rybicki LA, Sweetenham JW, Singh AD.
    Ophthalmology; 2013 Sep 01; 120(9):1915-9. PubMed ID: 23664470
    [Abstract] [Full Text] [Related]

  • 20. Superficial esophageal carcinoma.
    Sabik JF, Rice TW, Goldblum JR, Koka A, Kirby TJ, Medendorp SV, Adelstein DJ.
    Ann Thorac Surg; 1995 Oct 01; 60(4):896-901; discussion 902. PubMed ID: 7574991
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.